Melinjo (Gnetum gnemon L.) seeds are rich in resveratrol (RES) and its dimers, gnetin C and gnemonoside A.They have various pharmacol. benefits, and antioxidant and anti-inflammatory properties; however, their pharmacokinetics, especially in animal models, must be better understood.This study aimed to elucidate the pharmacokinetics of melinjo seed extract (MSE) components in rats.Plasma samples were collected up to 24 h after intergastric administration of MSE (1000 mg/kg), gnetin C, or gnemonoside A (51 μmol/kg each).RES was present as conjugates, with maximum plasma concentration (1065 nM) achieved at 6 h postadministration of MSE.The plasma concentrations of gnetin C and gnemonoside A following MSE administration were sustained, and their absorption rates, based on the AUC-dose relationship, reached 13.7 and 4.8%, resp., and higher than that of each standard alone.These findings indicate that MSE enhances the absorption of RES and its derivatives, potentially supporting their therapeutic applications and functional foods.